NovaDel Pharma, Inc. (AMEX: NVD), a specialty pharmaceutical company, is focused on developing oral spray formulations of a wide array of marketed therapeutics. NovaMist™, the Company’s proprietary technology, allows drugs to be rapidly delivered directly into the bloodstream, which results in faster onset of action and may provide patient benefits in compliance, convenience and safety. Currently, NovaDel’s most advanced candidates are designed to treat angina, insomnia, and nausea. For further information, visit the Company’s web site at www.novadel.com.
- 17 years ago
QualityStocks
NovaDel Pharma, Inc. (AMEX: NVD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
VolitionRx Ltd. (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced that it is preparing a reimbursement submission for its Nu.Q®…
-
QualityStocksNewsBreaks – Brand Engagement Network Inc. (NASDAQ: BNAI) Reports Warrant Exercises, Debt Conversion, and Public Warrants Update
Brand Engagement Network Inc. (NASDAQ: BNAI) announced on Wednesday that it generated approximately $1.46 million…
-
Soligenix (NASDAQ: SNGX) Positioning for Impact in Growing Rare-Disease Landscape
The World Health Organization’s recent recognition of rare diseases as a global health priority underscores…